The Prostate Health Education Network: Prostate Health Education and Awareness

Clinical Trials

Study of a Monoclonal Antibody and Ketoconazole in Patients with Prostate Cancer Number: NCT00859781 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Weill Medical College of Cornell University Sponsor Trial Information Trial Location(s) and Contact(s)	RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study) Number: NCT02090114 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s)
Use of Ligand-Inducible Autologous T Cells Engineered to Target PSCA on Tumor Cells in Selected Advanced Solid Tumors Number: NCT02744287 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): Bellicum Pharmaceuticals Sponsor Trial Information Trial Location(s) and Contact(s)	Pembrolizumab and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer Number: NCT03406858 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Barbara Ann Karmanos Cancer Institute\|National Cancer Institute (NCI) Sponsor Trial Information Trial Location(s) and Contact(s)
Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer Number: NCT03800784 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2\| Phase 3 Sponsor(s): Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Sponsor Trial Information Trial Location(s) and Contact(s)	Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer Number: NCT03999515 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Washington\|National Cancer Institute (NCI)\|Janssen Research & Development, LLC Sponsor Trial Information Trial Location(s) and Contact(s)
Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC) Number: NCT04157088 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Bayer Sponsor Trial Information Trial Location(s) and Contact(s)	Study in Patients With Advanced Cancers Associated With Expression of DLL3 Who Have Failed Standard Available Therapy Number: NCT04471727 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): Harpoon Therapeutics Sponsor Trial Information Trial Location(s) and Contact(s)
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies Number: NCT04503265 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1\|Phase 2 Sponsor(s): AtlasMedx, Incorporated Sponsor Trial Information Trial Location(s) and Contact(s)	Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer Number: NCT04666129 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 1 Sponsor(s): Myovant Sciences GmbH Sponsor Trial Information Trial Location(s) and Contact(s)
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer Number: NCT04725903 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): Emory University Sponsor Trial Information Trial Location(s) and Contact(s)

Total: 11 Clinical Trials